Skip to content
healthcare.dev
Get a free key

Neo-Synephrine Severe

NDC 0225-0811, PHENYLEPHRINE HYDROCHLORIDE, spray, from BF ASCHER AND CO INC.

Product NDC
0225-0811
Status
Listed
Labeler
BF ASCHER AND CO INC
Dosage form
SPRAY
Route
NASAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0225-0811 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PHENYLEPHRINE HYDROCHLORIDE1 g/100mL

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0225-0811-470022508114715 mL in 1 BOTTLE, SPRAY (0225-0811-47)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0225-0811 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0225-0811 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0225-0811. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.